CXCL8 and prostate carcinoma: They are recruited to the prostate cancer TME primarily through binding of C-X-C motif ligand 5 on prostate cancer cells with C-X-C motif receptor 2 on MDSCs, as well as through IL-8-mediated chemotaxis [18, 19].